Dr. Nazneen Dewji is a distinguished figure in the field of Alzheimer's research. She is the Founder and CEO of Cenna Biosciences, a biopharmaceutical company in La Jolla, California, dedicated to developing new treatments for Alzheimer's disease. Cenna is advancing a patented technology that targets the accumulation of the toxic Aß species, a fundamental cause of Alzheimer's, with the goal of establishing a disease-modifying drug.